Pfizer will offer the vaccine — which protects children against pneumonia, among other diseases — in a new multi-dose vial at the lowest prevailing global price of $3.10 per dose, according to the report.
The drugmaker will also donate all the money raised from sales of the vaccine throughout the first year of the initiative to humanitarian groups, according to a company statement.
More articles on population health:
Geisinger launches fresh food pharmacy
Fentanyl overtakes heroin as the most deadly opioid in Massachusetts
St. Louis sees almost 2 dozen synthetic opioid overdoses in 24 hours: 4 things to know
